ArticleFrontiers in immunology2021

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.

Lili Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.